XML 50 R29.htm IDEA: XBRL DOCUMENT
v3.25.2

Goodwill and Other Intangible Assets (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Goodwill by Reportable Segment | The following table summarizes the changes in the carrying amount of goodwill for the two reportable segments and the remaining operating segments, included in Other and in total:
(in millions) | Pharmaceutical and Specialty Solutions |  | Global Medical Products and Distribution (1) |  | Other (2) (3) |  | Total
Balance at June 30, 2023 | $ | 2,762 |  |  | $ | 681 |  |  | $ | 1,170 |  |  | $ | 4,613 |
Goodwill acquired, net of purchase price adjustments | 793 |  |  | (3) |  |  | — |  |  | 790 |
Foreign currency translation adjustments and other | — |  |  | (3) |  |  | — |  |  | (3) |
Goodwill Impairment | — |  |  | (675) |  |  | — |  |  | (675) |
Balance at June 30, 2024 | $ | 3,555 |  |  | $ | — |  |  | $ | 1,170 |  |  | $ | 4,725 |
Goodwill acquired, net of purchase price adjustments | 4,389 |  |  | — |  |  | 578 |  |  | 4,967 |
Foreign currency translation adjustments and other | (1) |  |  | — |  |  | — |  |  | (1) |
Balance at June 30, 2025 | $ | 7,943 |  |  | $ | — |  |  | $ | 1,748 |  |  | $ | 9,691 |
(1) At June 30, 2025 and 2024, the GMPD segment accumulated goodwill impairment loss was $5.4 billion. (2) At June 30, 2025 and 2024, the Nuclear and Precision Health Solutions accumulated goodwill impairment loss was $829 million. (3) Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics. The increase in the Pharma segment goodwill is primarily due to the GIA and ION acquisitions that occurred during fiscal 2025. The increase in the Other segment goodwill is due to the ADS acquisition that occurred during fiscal 2025. Goodwill recognized in connection with these acquisitions primarily represent the expected benefits from the expected growth from new customers, the assembled workforce of the acquired entities, and synergies of integrating these businesses. Substantially all of the goodwill recorded is expected to be nondeductible for income tax purposes. During fiscal 2025, we did not identify any indicators of impairment within our reporting units. We performed interim quantitative goodwill impairment testing for GMPD at September 30, 2023 and March 31, 2024, which resulted in pre-tax goodwill impairment charges of $585 million and $90 million, respectively. GMPD goodwill was fully impaired during the third quarter of fiscal 2024. During fiscal 2023, GMPD had cumulative pre-tax impairment charges of $1.2 billion. These goodwill impairment charges are recorded in impairments and (gain)/loss on disposal of assets, net in our consolidated statements of earnings. In connection with the divestiture of the Outcomes business, during fiscal 2023, we allocated and reclassified $24 million of goodwill from the Pharma operating segment to the Outcomes disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that was retained.
Schedule of Finite-Lived Intangible Assets | The following tables summarize other intangible assets by class at June 30:
| 2025
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible |  | Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles: |  |  |  |  |  |  |
Trademarks and patents | $ | 13 |  |  | $ | — |  |  | $ | 13 |  |  | N/A
Total indefinite-life intangibles | 13 |  |  | — |  |  | 13 |  |  | N/A
Definite-life intangibles: |  |  |  |  |  |  |
Customer intangibles | 3,876 |  |  | 2,639 |  |  | 1,237 |  |  | 11
Trademarks, trade names, and patents | 1,340 |  |  | 459 |  |  | 881 |  |  | 8
Developed technology and other | 1,030 |  |  | 726 |  |  | 304 |  |  | 6
Non-Competition Agreements | 72 |  |  | 21 |  |  | 51 |  |  | 4
Total definite-life intangibles | 6,318 |  |  | 3,845 |  |  | 2,473 |  |  | 10
Total other intangible assets | $ | 6,331 |  |  | $ | 3,845 |  |  | $ | 2,486 |  |  | N/A
| 2024
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible
Indefinite-life intangibles: |  |  |  |  |
Trademarks and patents | $ | 12 |  |  | $ | — |  |  | $ | 12 |
Total indefinite-life intangibles | 12 |  |  | — |  |  | 12 |
Definite-life intangibles: |  |  |  |  |
Customer intangibles | 3,628 |  |  | 2,431 |  |  | 1,197 |
Trademarks, trade names, and patents | 561 |  |  | 408 |  |  | 153 |
Developed technology and other | 1,047 |  |  | 684 |  |  | 363 |
Total definite-life intangibles | 5,236 |  |  | 3,523 |  |  | 1,713 |
Total other intangible assets | $ | 5,248 |  |  | $ | 3,523 |  |  | $ | 1,725 |
Schedule of Indefinite-Lived Intangible Assets | The following tables summarize other intangible assets by class at June 30:
| 2025
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible |  | Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles: |  |  |  |  |  |  |
Trademarks and patents | $ | 13 |  |  | $ | — |  |  | $ | 13 |  |  | N/A
Total indefinite-life intangibles | 13 |  |  | — |  |  | 13 |  |  | N/A
Definite-life intangibles: |  |  |  |  |  |  |
Customer intangibles | 3,876 |  |  | 2,639 |  |  | 1,237 |  |  | 11
Trademarks, trade names, and patents | 1,340 |  |  | 459 |  |  | 881 |  |  | 8
Developed technology and other | 1,030 |  |  | 726 |  |  | 304 |  |  | 6
Non-Competition Agreements | 72 |  |  | 21 |  |  | 51 |  |  | 4
Total definite-life intangibles | 6,318 |  |  | 3,845 |  |  | 2,473 |  |  | 10
Total other intangible assets | $ | 6,331 |  |  | $ | 3,845 |  |  | $ | 2,486 |  |  | N/A
| 2024
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible
Indefinite-life intangibles: |  |  |  |  |
Trademarks and patents | $ | 12 |  |  | $ | — |  |  | $ | 12 |
Total indefinite-life intangibles | 12 |  |  | — |  |  | 12 |
Definite-life intangibles: |  |  |  |  |
Customer intangibles | 3,628 |  |  | 2,431 |  |  | 1,197 |
Trademarks, trade names, and patents | 561 |  |  | 408 |  |  | 153 |
Developed technology and other | 1,047 |  |  | 684 |  |  | 363 |
Total definite-life intangibles | 5,236 |  |  | 3,523 |  |  | 1,713 |
Total other intangible assets | $ | 5,248 |  |  | $ | 3,523 |  |  | $ | 1,725 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration